1341 – 1350 of 1519
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Risk Factors for Nursing Home Placement in Alzheimer's Disease: A Longitudinal Study of Cognition, ADL, Service Utilization, and Cholinesterase Inhibitor Treatment.
- Contribution to journal › Article
-
Mark
Regional Differences in Effects of APOE epsilon 4 on Cognitive Impairment in Non-Demented Subjects
- Contribution to journal › Article
- 2010
-
Mark
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
- Contribution to journal › Article
-
Mark
Association of the RAGE G82S polymorphism with Alzheimer's disease
- Contribution to journal › Article
-
Mark
The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease
- Contribution to journal › Article
-
Mark
A beta 40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease
- Contribution to journal › Article
-
Mark
BACE1 gene variants do not influence BACE1 activity, levels of APP or A beta isoforms in CSF in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease
- Contribution to journal › Article
-
Mark
The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of A beta in different brain regions
- Contribution to journal › Article
